Pharmaron | Briefing, News, Analysis, Research, Data

Pharmaron

Pharmaron and is committed to helping partners succeed in drug discovery'

Pharmaron is a global pharmaceutical company, biotech company and research institute that provides fully integrated drug discovery, development and manufacturing CRMO solutions across the two stages of drug discovery and drug development, and is committed to helping partners succeed in drug discovery, development and commercialization.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jan 1, 2003

HQ location

Beijing, China

Legal name

Pharmaron Beijing Co., Ltd.

Website

http://www.pharmaron.com/

pharmaron@pharmaron-bj.com

Employees

1001-5000

All
News
Analysis
Research

Briefing Jun 24, 2022 10:39 AM · Technology | Healthcare | Industrials

The maximum payment limit of employee medical insurance in Shanghai in 2022 was raised to 590000 yuan

Briefing Jun 07, 2022 10:37 AM · Healthcare | Real Estate | Industrials

The port sector continued to strengthen and Guangzhou port rose by the daily limit

In-depth

Healthcare

Immunotherapy in China: A Rising Star in the Field of Cancer Treatment

Immunotherapy is emerging as a powerful weapon in fighting cancer by restarting and maintaining the cancer-immunity cycle to identify, control and eliminate tumor cells rather than killing them directly.

Nov 24, 2022 06:29 PM

Briefing Apr 26, 2022 10:40 AM · Consumer Staples | Healthcare | Industrials

Runfeng shares: exchange rate changes have little impact on the company's performance

Briefing Apr 19, 2022 11:34 AM · Consumer Staples | Healthcare | Financials

The steel plate rose and Jinling mining rose by the limit

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Financials, Technology

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Mar 10, 2022 09:49 AM · Healthcare | Financials | Automotive

Traditional Chinese medicine stocks rose and strengthened, and Dali pharmaceutical touched the daily limit

Briefing Feb 25, 2022 10:38 AM · Technology | Healthcare | Financials

"Zhongke spectral light" completed tens of millions of yuan of round a financing

Briefing Feb 21, 2022 10:29 AM · Healthcare

Baidu responded that it was unable to search "referee document network": caused by misoperation of the technical team

Briefing Feb 16, 2022 01:29 PM · Consumer Staples | Healthcare | Automotive

According to the needs of epidemic prevention and control, the operation of Suzhou passenger transport line was suspended

Healthcare

Fully Native Human mAb Drug Developer Trinomab Raises CNY 750 Mn in Pre-IPO Round

Despite increasing competition, the prospect of the monoclonal antibody drug market in China remains promising.

Yesterday 05:53 PM

Healthcare

Biotech Rgenta Wins USD 52 Mn in Series A Funding Round

The precise regulation of RNA target sites is expected to regulate protein expression from upstream, intervene in traditionally undruggable targets, and control diseases.

Yesterday 01:02 PM

Briefing Feb 15, 2022 10:49 AM · Automotive | Technology | Communication

The whole vehicle sector rose in shock, and Shuguang shares closed the limit

Briefing Feb 08, 2022 04:50 PM

GAC group: in January, the automobile sales volume was about 237200, with a year-on-year increase of 9.16%

Briefing Feb 08, 2022 09:39 AM · Consumer Staples | Healthcare | Financials

The digital currency sector opened sharply lower

Insight

Healthcare

Challenges and Opportunities Possessed by Digital Therapeutics Industry

Following the digital therapeutics series report, this article is centered on the challenges and opportunities faced by the digital therapeutics industry and aims to provide insights on the two above aspects.

Nov 23, 2022 03:23 PM

Healthcare

Yaohabio Secures Over CNY 100 Mn in the Series B+ Round

A full-scale CRDMO combines a CRO and CDMO business model, resulting in a fully integrated suite of end-to-end solutions to meet future market demand.

Nov 21, 2022 07:06 PM

Briefing Jan 26, 2022 01:19 PM · Consumer Staples | Healthcare | Automotive

Kia's fourth quarter sales were 17.19 trillion won, lower than expected

Briefing Jan 25, 2022 07:30 PM · Technology | Automotive

GE's total revenue in the fourth quarter was $20.3 billion and is expected to be $21.4 billion.

Briefing Jan 25, 2022 05:40 PM · Technology | Consumer Staples

First environmental protection: it is proposed to issue renewable corporate bonds of no more than 6 billion yuan

Briefing Jan 21, 2022 07:29 PM · Technology | Healthcare | Financials

Jinyuan shares: Xu Gang, chairman of the board, plans to increase his holding of shares of no less than 15 million yuan

EqualOcean Analysis